安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Spyre Therapeutics
Spyre is developing next-generation antibodies that are engineered for prolonged activity in the body and formulated for delivery as monotherapies or combination therapies
- Spyre Therapeutics, Inc. (SYRE) - Yahoo Finance
Spyre Therapeutics, Inc , a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD) and rheumatic diseases
- Spyre Therapeutics Reports First Quarter 2026 Financial Results and . . .
Spyre Therapeutics is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD
- Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics . . .
Spyre Therapeutics is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining best-in-class antibody engineering, rational
- SYRE Stock Price | Spyre Therapeutics Inc. Stock Quote (U. S. : Nasdaq . . .
Spyre Therapeutics, Inc is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other
- Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics
Spyre Therapeutics is a biotechnology company advancing a robust pipeline of antibody therapeutics with the potential to transform the treatment of inflammatory bowel disease (IBD)
- Spyre Therapeutics (SYRE) Stock Price, News Analysis
Established by a team with deep expertise in protein design, immunology and translational research, Spyre Therapeutics collaborates with leading academic institutions and research organizations to accelerate its discovery efforts
- SYRE Stock Price Quote | Morningstar
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease
|
|
|